NCT03144115

Brief Summary

The aim of the study is to explore how the rewarding effect of men's verbal compliment is modulated by oxytocin and gonadal hormone in a romantic context.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P75+ for early_phase_1 healthy

Timeline
Completed

Started Oct 2016

Typical duration for early_phase_1 healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2016

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

May 4, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 8, 2017

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
Last Updated

October 29, 2018

Status Verified

October 1, 2018

Enrollment Period

1.7 years

First QC Date

May 4, 2017

Last Update Submit

October 26, 2018

Conditions

Keywords

oxytocinsex hormoneverbal rewardmate selectionmetaphorical language

Outcome Measures

Primary Outcomes (1)

  • Oxytocin effect on neural activity as assessed via fMRI towards reward between fertility and luteal phases

    Effects of oxytocin versus placebo nasal spray on neural processing of reward will be compared between different cycle phases

    45min-120min after treatment

Study Arms (4)

oxytocin fertility

EXPERIMENTAL

intranasal oxytocin administration (24IU) in women's fertility phase (LH\>40 mIU/ml)

Drug: Oxytocin

placebos fertility

PLACEBO COMPARATOR

intranasal placebo administration (24IU) in women's fertility phase (LH\>40 mIU/ml)

Drug: Placebos

oxytocin luteal

EXPERIMENTAL

intranasal oxytocin administration (24IU) in women's luteal phase (LH\<30 mIU/ml)

Drug: Oxytocin

placebos luteal

PLACEBO COMPARATOR

intranasal placebos administration (24IU) in women's luteal phase (LH\<30 mIU/ml)

Drug: Placebos

Interventions

Also known as: oxytocin treatment
oxytocin fertilityoxytocin luteal
Also known as: placebo control
placebos fertilityplacebos luteal

Eligibility Criteria

Age18 Years - 25 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Single in the past 3 months
  • Healthy subjects with regular menstrual cycle

You may not qualify if:

  • Pregnant, menstruating, taking oral contraceptives
  • metal implanted, with tatoo, or hair dyed within 6 months
  • participated in another intranasal experiment within 6 months
  • with a history of past or current psychiatric or neurological disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Electronic Science and Technology of Chia

Chengdu, Sichuan, 611731, China

Location

Related Publications (1)

  • Gao Z, Ma X, Zhou X, Xin F, Gao S, Kou J, Becker B, Kendrick KM. Oxytocin Reduces the Attractiveness of Silver-Tongued Men for Women During Mid-Cycle. Front Neurosci. 2022 Apr 28;16:760695. doi: 10.3389/fnins.2022.760695. eCollection 2022.

MeSH Terms

Interventions

Oxytocin

Intervention Hierarchy (Ancestors)

Pituitary Hormones, PosteriorPituitary HormonesPeptide HormonesHormonesHormones, Hormone Substitutes, and Hormone AntagonistsPeptidesAmino Acids, Peptides, and Proteins

Study Officials

  • Keith M Kendrick, Dr.

    University of Electronic Science and Technology of China

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 4, 2017

First Posted

May 8, 2017

Study Start

October 1, 2016

Primary Completion

June 1, 2018

Study Completion

July 1, 2018

Last Updated

October 29, 2018

Record last verified: 2018-10

Locations